62 related articles for article (PubMed ID: 9058624)
21. Autoimmune liver disease. Current standards, future directions.
Gish RG; Mason A
Clin Liver Dis; 2001 May; 5(2):287-314. PubMed ID: 11385965
[TBL] [Abstract][Full Text] [Related]
22. Ursodeoxycholic acid and bile-acid mimetics as therapeutic agents for cholestatic liver diseases: an overview of their mechanisms of action.
Poupon R
Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S3-12. PubMed ID: 23141891
[TBL] [Abstract][Full Text] [Related]
23. [Primary biliary cirrhosis].
Corpechot C
Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 1):320-4. PubMed ID: 12700520
[No Abstract] [Full Text] [Related]
24. Primary biliary cirrhosis. Is (and how much of) the pathology preventible?
Bar-Dayan Y; Gershwin ME; Levi Y; Amital H; Shoenfeld Y
Immunol Res; 1998; 18(2):117-23. PubMed ID: 9844830
[TBL] [Abstract][Full Text] [Related]
25. [Treatment of cholestatic liver diseases with ursodeoxycholic acid].
Boberg KM; Schrumpf E
Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890
[TBL] [Abstract][Full Text] [Related]
26. The challenges of primary biliary cholangitis: What is new and what needs to be done.
Terziroli Beretta-Piccoli B; Mieli-Vergani G; Vergani D; Vierling JM; Adams D; Alpini G; Banales JM; Beuers U; Björnsson E; Bowlus C; Carbone M; Chazouillères O; Dalekos G; De Gottardi A; Harada K; Hirschfield G; Invernizzi P; Jones D; Krawitt E; Lanzavecchia A; Lian ZX; Ma X; Manns M; Mavilio D; Quigley EM; Sallusto F; Shimoda S; Strazzabosco M; Swain M; Tanaka A; Trauner M; Tsuneyama K; Zigmond E; Gershwin ME
J Autoimmun; 2019 Dec; 105():102328. PubMed ID: 31548157
[TBL] [Abstract][Full Text] [Related]
27. Treatment of primary biliary cirrhosis.
Poupon R; Poupon RE
Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):615-28. PubMed ID: 10976018
[TBL] [Abstract][Full Text] [Related]
28. Combination therapy of ursodeoxycholic acid and budesonide for PBC-AIH overlap syndrome: a meta-analysis.
Zhang H; Yang J; Zhu R; Zheng Y; Zhou Y; Dai W; Wang F; Chen K; Li J; Wang C; Li S; Liu T; Abudumijiti H; Zhou Z; Wang J; Lu W; Wang J; Xia Y; Zhou Y; Lu J; Guo C
Drug Des Devel Ther; 2015; 9():567-74. PubMed ID: 25632224
[TBL] [Abstract][Full Text] [Related]
29. Proposed therapies in primary biliary cholangitis.
Floreani A; Sun Y; Zou ZS; Li B; Cazzagon N; Bowlus CL; Gershwin ME
Expert Rev Gastroenterol Hepatol; 2016; 10(3):371-382. PubMed ID: 26577047
[TBL] [Abstract][Full Text] [Related]
30. Primary biliary cirrhosis in adults.
Momah N; Lindor KD
Expert Rev Gastroenterol Hepatol; 2014 May; 8(4):427-33. PubMed ID: 24580040
[TBL] [Abstract][Full Text] [Related]
31. The use of ursodeoxycholic acid in patients with primary biliary cirrhosis: sense or nonsense.
Van Den Bogaert E; Francque S; Pelckmans P; Michielsen P
Acta Gastroenterol Belg; 2003; 66(4):283-7. PubMed ID: 14989050
[TBL] [Abstract][Full Text] [Related]
32. Primary biliary cirrhosis: overlaps with other autoimmune disorders.
Floreani A; Franceschet I; Cazzagon N
Semin Liver Dis; 2014 Aug; 34(3):352-60. PubMed ID: 25057958
[TBL] [Abstract][Full Text] [Related]
33. Management of cholestatic disease in 2017.
de Vries E; Beuers U
Liver Int; 2017 Jan; 37 Suppl 1():123-129. PubMed ID: 28052628
[TBL] [Abstract][Full Text] [Related]
34. Primary biliary cirrhosis: therapeutic advances.
Czul F; Peyton A; Levy C
Clin Liver Dis; 2013 May; 17(2):229-42. PubMed ID: 23540499
[TBL] [Abstract][Full Text] [Related]
35. Novel and emerging therapies for cholestatic liver diseases.
Goldstein J; Levy C
Liver Int; 2018 Sep; 38(9):1520-1535. PubMed ID: 29758112
[TBL] [Abstract][Full Text] [Related]
36. Obeticholic acid for the treatment of primary biliary cholangitis.
Ali AH; Lindor KD
Expert Opin Pharmacother; 2016 Sep; 17(13):1809-15. PubMed ID: 27468093
[TBL] [Abstract][Full Text] [Related]
37. The natural history of primary biliary cirrhosis.
Imam MH; Lindor KD
Semin Liver Dis; 2014 Aug; 34(3):329-33. PubMed ID: 25057955
[TBL] [Abstract][Full Text] [Related]
38. Ursodeoxycholic acid for primary biliary cirrhosis.
Drug Ther Bull; 1999 Apr; 37(4):30-2. PubMed ID: 10563063
[TBL] [Abstract][Full Text] [Related]
39. Options for treatment of primary biliary cirrhosis.
Oo YH; Neuberger J
Drugs; 2004; 64(20):2261-71. PubMed ID: 15456326
[TBL] [Abstract][Full Text] [Related]
40. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis.
Lindor K
N Engl J Med; 2007 Oct; 357(15):1524-9. PubMed ID: 17928600
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]